Gen-Next-Probiotics-and-Microbiome-Congress | February 6 - 7, 2020

CONFERENCE AGENDA

Registration	07:50 - 08:50
Opening note by MarketsandMarkets	08:50 - 08:55
Opening remarks by Chairman	08:55 - 09:00
TACKLING THE MECHANISM OF ACTION THROUGH MICROBIOTA AND PROBIOTIC FUNCTIONALITY
Small Molecule Mining of Human Surrogate Microbiome for Therapeutics Ross Youngs, CEO & Founder, Biosortia Pharmaceuticals	09:00 - 09:30
Clinical trials on the microbiome, what we learned so far Dr. Sabine Hazan, Founder/ CEO, ProgenaBiome, Ventura Clinical Trials, Malibu Specialty Center	09:30 - 10:00
Morning refreshment and Networking	10:00 - 10:50
The Unique Microbiome of the Human Infant David Kyle, Executive Chairman and CSO, Evolve BioSystems, Inc	10:50 - 11:15
Powerful therapeutic effects - using Live Probiotic Technology in wound care Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech	11:15 - 11:40
The effect of skin care products on the skin microbiome and metabolome Chris Callewaert, Postdoctoral Research Fellow, Knight lab at University of California	11:40 - 12:05
Advancing Microbiome Research: From challenging samples to insight with confidence” Sujash Chatterjee, PhD., Genomics Application Specialist, QIAGEN	12:05 - 12:35
Evaluating neuroprotective effects of novel therapeutics using an alzheimer’s disease model that dramatically impacts gut microbiota dysbiosis Mo Kagalwala, Head of Business Development, Amylgen	12:35 - 12:50
Keynote presentation Will Polese, Vice President - Japan, Geo Head - West Region USA, MarketsandMarkets™	12:50 - 13:05
Lunch and Poster Presentations \| One-to-One Networking Meetings	13:05 - 14:05
ADDRESSING THE CHALLENGES IN MICROBIOME THERAPEUTICS
IP Protection as a Value Driver Michael Bush, President & CEO, Prenexus Health	14:05 - 14:30
Skin Microbiome as a Therapeutic Source: From Probiotic to Electrobiotic Eric Huang, Professor, University of California San Diego	14:30 - 14:55
Small intestine microbiome aspiration (simba) capsule: a new autonomous and minimally-invasive device for gut microbiome sampling, mapping and monitoring Gang (Joseph) Wang, CEO, Nimble Science	14:55 - 15:10
Getting past current limitations of sequencing for microbiome research Tuval Ben-Yehezkel, Founder & CEO, Loop Genomics	15:10 - 15:40
World-leading gut microbiome bioinformatics and bioprospecting capabilities of microba Dr. Kylie Ellis, Manager of Research Partnerships, Microba	15:40 - 15:55
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:55 - 16:45
EMERGING MICROBIAL TRENDS & THE FUTURE OF PROBIOTICS IN THE CONSUMER MARKETPLACE
Back to Health: What can we learn about health from the microbiome of hunter-gatherers Larry Weiss, CEO and Founder, Persona Biome, Inc.	16:45 - 17:10
Next-Generation Probiotics: Modulating Gut Microbiota for Health Wellness Andrea Azcarate-Peril, Associate Professor of Medicine, Director, UNC Microbiome Core, School of Medicine, University of North Carolina at Chapel Hill	17:10 - 17:35
Otc topical use of live probiotics for skin therapeutics Ellie Hang Trinh, Founder and Co-Owner, Skin Probiotics by Skin Recovery, LLC	17:35 - 18:00
Closing remarks	18:00 - 18:05
Drink Reception & Networking	18:05 - 19:05
End of Day 1	19:05 - 19:05

Registration	08:30 - 08:55
Opening note by MarketsandMarkets	08:55 - 09:00
Opening remarks by Chairman Bharath Prithiviraj, Microbiology Lead scientist, Ahara Biosciences, Inc	09:00 - 09:05
Viome’s systems biology platform for developing personalized nutrition algorithms based on molecular data Momchilo Vuyisich, Founder and Chief Science Officer, Viome, Inc	09:05 - 09:30
Pathogenesis inspired probiotic bioengineering to prevent enteric disease Arun Bhunia, Professor of Food Microbiology, Purdue University	09:30 - 09:55
Microbial systems: formulating microbial guilds for targeted metabolic outputs Martha Carlin, CEO, The BioCollective, LLC	09:55 - 10:10
Longitudinal microbiome-metabolome interaction analysis for clinical research Alexey Melnik, Metabolomics Lead, Clarity Genomics	10:10 - 10:25
Morning Refreshments and Poster Presentations \| One-to-One Networking Meetings	10:25 - 11:15
RAISING THE BAR: APPLYING NEW MICROBIOME SCIENCE & ANALYZING THE CONCEPT OF PROBIOTICS
Direct-Fed Microbials: Understanding Today’s Foundation Shaping Tomorrow’s Success A. Bruce Johnson, PhD, Corporate Vice President, Business Development, Phibro Animal Health Corporation	11:15 - 11:40
Gut-Brain axis mechanism of action and Clinical results on Hafnia alvei HA4597, a new probiotic strain for the regulation of appetite and weight management Gregory Lambert, CEO and VP Research and Development, TargEDys	11:40 - 12:10
Leveraging flow cytometry for accurate probiotic enumeration to support R&D and manufacturing decisions Jennie Starr, Director of Marketing , BioForm Solutions	12:10 - 12:25
Probiotic formulations- Compositional quality and ingredient interactions Shikha Snigdha, Director Of Innovation, MeriCal LLC	12:25 - 12:40
The Microbiome of Idiopathic Neurodegenerative Disease (MIND) Consortium Christopher Ellis, Sr. Staff Scientist , OAK Ridge National Laboratory	12:40 - 13:05
Gut Microbiome-based Disease Development and Drug Discovery Yu-Jui Yvonne Wan, Professor and Vice Chair for Research, Department of Pathology and Laboratory Medicine, University of California, Davis	13:05 - 13:30
Lunch and Poster Presentations \| One-to-One Networking Meetings	13:30 - 14:30
May the Fiber Be with You: Assessing Gut Microbiome Response to a High Fiber Diet Intervention	14:30 - 14:55
How the functionally targeted probiotics can be applied into consumer nutrition products for optimizing wellness? The presentation will include: Peter Leighton, CEO, ProSperity Bioscience	14:55 - 15:20
Species-level 16S Metagenome Analysis Via Simultaneous, Weighted Analysis of ALL Hypervariable Domains Seth Crosby, Director, Research Collaborations, Washington University School of Medicine	15:20 - 15:45
Closing remarks	15:45 - 15:50
End of Conference	15:50 - 15:50